Latest news
Obsidian Therapeutics Completes Closing of Transaction with Galera Therapeutics and Previously Announced Private Placement of $350 Million - Business WireBusiness Wire · Mon, 03 Aug 2026 13:00:00 GMTOctagon Denounces Decision by the Board of Trustees of XFLT to Delay the Shareholder Vote on the Proposed Sub-Adviser Transition - Business WireBusiness Wire · Thu, 30 Jul 2026 16:10:00 GMTPROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREA - GlobeNewswireGlobeNewswire · Wed, 29 Jul 2026 11:30:00 GMT